COMMUNIQUÉS West-GlobeNewswire

Tris Pharma Announces Positive Debut Data from Phase 3 ALLEVIATE-1 and 2 Trials Evaluating Cebranopadol in Acute Pain at AAPM PainConnect 2026 Annual Meeting
06/03/2026
Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (NMR) agonist which uses a novel approach of activating NOP and MOP receptors to work synergistically to modulate pain In both ALLEVIATE trials [...]
Karylief Tinnitus Supplement Claims Evaluated: 2026 Consumer Report Examines Karylief Hearing Support Ingredients, Proprietary Blend Transparency, and Research Context
06/03/2026
A 2026 informational consumer evaluation examining Karylief’s hearing health supplement marketing claims, ingredient research context, proprietary blend transparency, pricing disclosures, and verification considerations [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
06/03/2026
ZUG, Switzerland, March 06, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company. Attachments Notification of managers' [...]
CardioGLYX Blood Balance Support Claims Evaluated: 2026 Consumer Report Examines Blood Sugar, Cholesterol and Metabolic Ingredient Research
06/03/2026
A 2026 informational consumer research report analyzing CardioGLYX Blood Support marketing claims, ingredient research context, pricing disclosures, and verification considerations for adults researching metabolic [...]
EssilorLuxottica: 2025 Universal Registration Document filed
06/03/2026
2025 Universal Registration Document filed Paris, France (6 March 2026) – EssilorLuxottica announces the availability of its 2025 Universal Registration Document, in accordance with applicable regulation. The French [...]
Standard Dental Labs Inc.: Investor Education Series — Part 3
06/03/2026
Capital to Catalysts: Turning a Public Listing into a Deal Engine ORLANDO, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) today released Part 3 of its Investor Education Series, [...]
Transforming Healthcare Ltd Founder Dr. Pietro Emanuele Garbelli Wins BREW Readers' Book of the Month for 'The Doctor's Future'
06/03/2026
Transforming Healthcare Ltd founder recognised by BREW and profiled by The World’s Best on accountable AI, robotics, and the future of medicine London, GREATER LONDON, March 06, 2026 (GLOBE NEWSWIRE) -- London, UK — 6 [...]
Progyny, Inc. Executives to Participate in Upcoming Investor Conferences
06/03/2026
NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that several members of its leadership team will participate in [...]
SleepZee Anti-Snoring Mouthpiece Consumer Report: 2026 Analysis of Mandibular Advancement Device Research, Snoring Reduction Claims, and What Buyers Should Verify
06/03/2026
A 2026 informational consumer research report examining SleepZee anti-snoring mouthpiece mandibular advancement claims, boil-and-bite snoring mouth guard effectiveness research, company Terms of Service disclosures, [...]
VALNEVA Declaration of shares and voting rights: February 28, 2026
06/03/2026
VALNEVA Declaration of shares and voting rights February 28, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot Saint-Joseph [...]
Holland Bloorview Kids Rehabilitation Hospital launches its 10th annual Capes for Kids fundraiser
06/03/2026
Calling all fundraisers to don their capes from March 6-13 to support children with disabilities Toronto, March 06, 2026 (GLOBE NEWSWIRE) -- Holland Bloorview Kids Rehabilitation Hospital (Holland Bloorview) kicks off [...]
EssilorLuxottica: Mise à disposition du Document d’enregistrement universel 2025
06/03/2026
Mise à disposition du Document d’enregistrement universel 2025 Paris, France (6 mars 2026) – EssilorLuxottica annonce la mise à disposition de son Document d’enregistrement universel 2025 dans les conditions requises [...]
Nika Pharmaceuticals, Inc. (NIKA) Signed a Consultancy Agreement with MD Global Partners LLC
06/03/2026
HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA ) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. [...]
BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor
06/03/2026
BBO-11818 is a selective, orally bioavailable non-covalent inhibitor that targets KRAS in both the ON and OFF states, has high selectivity over HRAS and NRAS, and displays strong activity in KRAS mutant preclinical [...]
VALNEVA Déclaration d’actions et de droits de vote : 28 février 2026
06/03/2026
VALNEVA Déclaration d’actions et de droits de vote 28 février 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : Îlot [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
06/03/2026
Nantes, le 6 mars 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), société intégrée de [...]
Tangram Therapeutics annonce l’administration de la première dose à un participant dans le cadre de l’essai RESTORE-MASH de phase I/II portant sur le TGM-312, un nouveau médicament expérimental à base d’ARNi
06/03/2026
L’essai RESTORE-MASH de phase I/II évaluera la sécurité, la pharmacocinétique et la pharmacodynamique du TGM-312 chez des volontaires en bonne santé et des patients atteints de MASH Les premières données sont attendues [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
06/03/2026
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 6 March 2026 at 16.00 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook
06/03/2026
ACTON, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid near-patient tests to improve patient outcomes in [...]

Pages